Gulbanu Sarsenbayeva
Almaty, ALA, Kazakhstan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: April 03, 2026
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.
Journal: International journal of molecular sciences
Published: March 31, 2023
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan.
Journal: EClinicalMedicine
Published: April 05, 2021
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.
Journal: Human vaccines & immunotherapeutics
Published: February 13, 2020
Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Journal: Human vaccines & immunotherapeutics
Published: November 08, 2017
Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.
Journal: Journal of medical virology
Published: June 29, 2017
A novel preservative-free seasonal influenza vaccine safety and immune response study in the frame of preclinical research.
Journal: Journal of medical virology
Published: October 10, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026